Clinical Academic Training
Integrated Academic Training for medical and dental academics

75% of your time in specialist clinical training
25% of your time in research or educationalist training.
50% of your time in specialist clinical training
50% in research or educationalist training.
Register with Oriel
I studied medicine at St Bartholomews and The Royal London Hospitals before undertaking academic foundation training in the North of Scotland and a neurosurgical fellowship in Oxford. I developed a strong interest in the applications of artificial intelligence (AI), leading me to pursue a National Institute for Health and Care Research (NIHR)-funded Academic Clinical Fellowship (ACF) in Neurosurgery at the University of Plymouth, with enveloped neurosurgical residency. My ACF research has focused on the applications of AI and neuroimaging techniques to neurosurgery, particularly in the preoperative classification of brain tumours and implementation into clinical pipelines. I have recently been selected for the prestigious Lewis Spitz Surgeon-Scientist PhD Programme at Great Ormond Street Hospital and the Institute of Child Health at University College London, where I will study neuromodulative therapies for children with severe epilepsy.
I spent just over 12 months on the IAT programme, sneaking in before the end of ST4, which is the end of eligibility for IAT. The programme gave me the protected time I needed to develop credibility as a researcher – producing some small scale unfunded original research, as well as completing my Postgraduate Diploma in Medical Toxicology. I was able to use some academic time to build in a small secondment, which allowed me to form professional relationships which I could leverage into a PhD position. I received helpful mentorship and guidance from Professor Jason Smith, and found that Plymouth was a supportive environment to pursue my personal research interests. I wasn’t forced to develop a programme of work which I wasn’t passionate about. Since leaving the IAT, I have been working to deliver a phase 1 advanced therapy trial, a phase 2 small molecule trial, and have developed my own expertise in animal models, computer modelling, biomarker development, and therapeutic niche discovery. The reality is that I don’t think I would have been considered a credible candidate without the time the IAT programme gave me.